Pharmaceuticals Portfolio Pharmaceuticals Fund Alpha and Beta Analysis
| FPHAX Fund | USD 24.07 0.28 1.18% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Pharmaceuticals Portfolio Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Pharmaceuticals Portfolio over a specified time horizon. Remember, high Pharmaceuticals Portfolio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Pharmaceuticals Portfolio's market risk premium analysis include:
Beta 1.15 | Alpha (0.14) | Risk 1.57 | Sharpe Ratio (0.01) | Expected Return (0.01) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Pharmaceuticals |
Pharmaceuticals Portfolio Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Pharmaceuticals Portfolio market risk premium is the additional return an investor will receive from holding Pharmaceuticals Portfolio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pharmaceuticals Portfolio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Pharmaceuticals Portfolio's performance over market.| α | -0.14 | β | 1.15 |
Pharmaceuticals Portfolio expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Pharmaceuticals Portfolio's Buy-and-hold return. Our buy-and-hold chart shows how Pharmaceuticals Portfolio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Pharmaceuticals Portfolio Market Price Analysis
Market price analysis indicators help investors to evaluate how Pharmaceuticals Portfolio mutual fund reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharmaceuticals Portfolio shares will generate the highest return on investment. By understating and applying Pharmaceuticals Portfolio mutual fund market price indicators, traders can identify Pharmaceuticals Portfolio position entry and exit signals to maximize returns.
Pharmaceuticals Portfolio Return and Market Media
The median price of Pharmaceuticals Portfolio for the period between Sun, May 4, 2025 and Sat, Aug 2, 2025 is 24.59 with a coefficient of variation of 3.51. The daily time series for the period is distributed with a sample standard deviation of 0.86, arithmetic mean of 24.45, and mean deviation of 0.68. The Fund did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Pharmaceuticals Portfolio Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Pharmaceuticals or other funds. Alpha measures the amount that position in Pharmaceuticals Portfolio has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pharmaceuticals Portfolio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pharmaceuticals Portfolio's short interest history, or implied volatility extrapolated from Pharmaceuticals Portfolio options trading.
Build Portfolio with Pharmaceuticals Portfolio
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Other Information on Investing in Pharmaceuticals Mutual Fund
Pharmaceuticals Portfolio financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Portfolio security.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |